Analysts: Threshold Pharmaceuticals Inc (THLD.OQ)

THLD.OQ on NASDAQ Stock Exchange Capital Market

5.30USD
1 Aug 2013
Price Change (% chg)

$-0.12 (-2.21%)
Prev Close
$5.42
Open
$5.48
Day's High
$5.48
Day's Low
$5.26
Volume
125,670
Avg. Vol
127,854
52-wk High
$9.28
52-wk Low
$3.95

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.16 December 2 Aug 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 4 4
(2) OUTPERFORM 5 5 4 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.62 1.62 1.50 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 6 3.41 4.03 3.07 1.60
Quarter Ending Dec-13 6 3.66 4.98 3.07 1.60
Year Ending Dec-13 8 11.76 15.81 5.50 12.45
Year Ending Dec-14 8 12.82 17.90 6.00 26.73
Earnings (per share)
Quarter Ending Sep-13 5 -0.16 -0.09 -0.32 -0.13
Quarter Ending Dec-13 5 -0.17 -0.08 -0.39 -0.12
Year Ending Dec-13 6 -0.62 -0.38 -1.15 -0.30
Year Ending Dec-14 6 -0.53 -0.30 -0.76 -0.06

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 2.80 2.92 0.12 4.24
Quarter Ending Dec-12 2.85 2.02 0.83 29.15
Quarter Ending Sep-12 2.29 1.80 0.50 21.65
Quarter Ending Jun-12 1.69 1.80 0.11 6.31
Quarter Ending Mar-12 15.65 0.25 15.40 98.39
Earnings (per share)
Quarter Ending Mar-13 -0.09 -0.16 0.07 -81.82
Quarter Ending Dec-12 -0.09 0.50 0.59 -629.66
Quarter Ending Sep-12 -0.06 -0.02 0.04 -64.73
Quarter Ending Jun-12 -0.11 0.31 0.42 -388.37
Quarter Ending Mar-12 0.14 -0.15 0.29 210.29

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 3.41 3.41 3.41 3.41 1.60
Quarter Ending Dec-13 3.66 3.66 3.66 3.66 1.60
Year Ending Dec-13 11.76 11.76 11.76 11.55 12.45
Year Ending Dec-14 12.82 12.82 13.70 13.14 26.73
Earnings (per share)
Quarter Ending Sep-13 -0.16 -0.16 -0.16 -0.15 -0.13
Quarter Ending Dec-13 -0.17 -0.17 -0.17 -0.16 -0.12
Quarter Ending Dec-13 -0.62 -0.62 -0.61 -0.59 -0.30
Quarter Ending Dec-14 -0.53 -0.53 -0.51 -0.48 -0.06

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-13 0 0 0 0
Quarter Ending Dec-13 0 0 0 0
Year Ending Dec-13 0 0 0 0
Year Ending Dec-14 0 0 1 1
Earnings
Quarter Ending Sep-13 0 0 0 0
Quarter Ending Dec-13 0 0 0 2
Year Ending Dec-13 0 0 0 1
Year Ending Dec-14 0 0 0 1

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$460.00
Provider: S&P Capital IQ Quantitative Report
$58.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks